Adaptive Biotechnologies Corporation (ADPT) financial statements and ratios from SEC XBRL: revenue $276.98M (TTM), net margin -21.5%, revenue growth 21.5% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $276.98M |
| Net Margin | -21.5% |
| Revenue Growth (YoY) | 21.5% |
| EPS Growth (YoY) | 47.1% |
| FCF Growth (YoY) | -42.0% |
| Price / Book | 27.02 |
| Price / Sales | 13.22 |
| FCF Yield | -0.9% |
| Altman Z-Score | 5.11 (safe) |
| Piotroski F-Score | 5/9 |
| Sector P/E (Healthcare) | 21.6 |
ADPT overview · ADPT earnings · ADPT KPIs · ADPT investor relations · ADPT ownership · ADPT peers · ADPT filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.